Human Renal Cell Carcinoma Induces a Dendritic Cell Subset That Uses T-Cell Crosstalk for Tumor-Permissive Milieu Alterations
- 31 July 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 179 (1), 436-451
- https://doi.org/10.1016/j.ajpath.2011.03.011
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Unravelling mononuclear phagocyte heterogeneityNature Reviews Immunology, 2010
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunityCancer and Metastasis Reviews, 2010
- Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic CellsCancer Research, 2009
- Tumor-Induced Suppression of CTL Expansion and Subjugation by gp96-Ig VaccinationCancer Research, 2009
- Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccineMolecular Immunology, 2009
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- Dendritic cells facilitate accumulation of IL-17T cells in the kidney following acute renal obstructionKidney International, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Tumor‐derived tumor necrosis factor‐alpha promotes progression and epithelial‐mesenchymal transition in renal cell carcinoma cellsCancer Science, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005